Agricultural technology companies continue to seek innovative methods to enhance sustainability in farming. Fyteko, an agritech firm based in Anderlecht, Belgium, is progressing in this field by securing €13 million in a Series B funding round. The company aims to further develop its biosolutions designed to improve crop resilience and reduce reliance on chemical treatments. With increasing concerns over climate change and food security, such advancements play a role in fostering sustainable agricultural practices.
Fyteko has previously received funding for its research and development efforts, including support from the European Union’s Horizon 2020 programme. This initiative enabled the company to conduct field trials across multiple EU countries and refine its product formulations. Compared to earlier funding rounds, the latest investment represents a significant step in scaling up operations and broadening its market presence. Over the years, Fyteko has expanded its scope, increasing the number of field trials and strengthening the efficacy of its biostimulant products.
Who are the key investors?
The latest funding round was led by Crédit Mutuel Impact, with additional support from SFPIM, Supernova Invest, IMBC, finance&invest.brussels, EIT Food, and the Innovation Fund. These investors recognize the potential of Fyteko’s biosolutions in addressing agricultural sustainability challenges while aligning with broader environmental goals. Their participation provides financial backing for Fyteko’s next phase of development and market expansion.
“We see a future where the world’s farmers can feed a growing population, using safe and sustainable inputs,” said Fyteko, emphasizing the company’s long-term mission.
What products does Fyteko offer?
Fyteko has developed several agricultural products based on bio-based molecules to enhance crop resilience. These include Nurspray, a foliar biostimulant that strengthens plants against drought and extreme weather conditions; Nurseed, a seed treatment that promotes strong early growth under stress; and Nursoil, a soil-drench biostimulant that activates plants’ natural defense mechanisms. These products aim to help farmers optimize yields while reducing dependency on synthetic chemicals.
The company has conducted extensive field trials, with more than 500,000 hectares treated in 2024. Fyteko has also filed six patent families related to its proprietary technologies. The firm’s approach combines scientific research with practical agricultural applications, supporting the transition to climate-smart farming.
Fyteko’s expansion aligns with a broader agricultural shift towards sustainable and eco-friendly farming methods. As climate change continues to impact crop production, solutions that improve resilience while maintaining productivity are gaining interest. The financial backing from major investors indicates confidence in Fyteko’s ability to contribute to this transition. However, competition in the biostimulant sector is also increasing, with various companies developing similar solutions to address climate-related challenges in agriculture.
The company’s future efforts will likely focus on scaling production, expanding into new markets, and improving the efficacy of its bio-based treatments. Farmers seeking alternatives to chemical-based solutions may find Fyteko’s products useful in adapting to changing environmental conditions. As demand for sustainable farming grows, the success of such biosolutions will depend on their effectiveness in real-world agricultural settings.
